Medical Weight Loss for Westbrook, Maine Residents

Westbrook, Maine residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Westbrook through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Skip the commute, keep the care: from downtown Westbrook and the greater Portland metro area of Cumberland County and anywhere else in Westbrook, you meet your physician on a video call from home or work. We confirm telehealth eligibility during the consultation. Doctor review just $119 (medication separate).

Why Westbrook Residents Choose New Hope Weight Loss

What draws a lot of Westbrook patients to New Hope is the honest pricing. Semaglutide starts at $166 a month and tirzepatide at $233 a month, with a $119 physician visit, and that is the whole conversation. There is no surprise line item, no distance surcharge for living outside Costa Mesa, and no pressure to buy a bundle you did not ask for. You see the real numbers before you commit, which is how it should be.

Medical weight loss for Westbrook is handled end-to-end online: intake, the $119 physician review with Dr. Sharma, dose titration, and follow-ups, all by secure video, with no drive and no pharmacy line.

There is no New Hope Weight Loss office in Westbrook, and there does not need to be, since the same doctor-led program is delivered to every corner of Maine through telehealth visits. We care for patients throughout downtown Westbrook and the greater Portland metro area of Cumberland County. Your intake, lab review, and dosing are all overseen by a physician, which means real medical supervision behind every package sent to Westbrook.

Whether you live in central Westbrook or out toward the edges of Maine, you see the same physician, Dr. Anjmun Sharma, and pay the same flat pricing with no distance surcharge. The 90-day semaglutide program is $499, which works out to a lower monthly cost than paying month to month for many Westbrook patients. Even in the more remote corners of Maine, New Hope Weight Loss reaches patients by secure telehealth from our Costa Mesa, California clinic, so distance never limits your care.

GLP-1 Weight Loss Programs Available

Which GLP-1 program is right for you?

Our 90-Day Metabolic Reset runs on semaglutide, the same active ingredient as Wegovy and Ozempic. It starts at $166 a month, or $499 for 90 days, and branded-drug trials reported average loss near 15 to 17 percent. Because compounded semaglutide is not FDA-approved or brand-identical, results vary. Dr. Sharma guides every Westbrook patient by telehealth.

And if you want more horsepower

Tirzepatide, from $233 a month, adds GIP to the usual GLP-1 action. In branded-drug trials, dose-qualified participants reached up to 22.5 percent loss, which is not the typical outcome. It shares its active ingredient with Mounjaro and Zepbound.

A $119 physician review starts the process. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Westbrook

Telehealth means your weight-loss care travels to you instead of the other way around. Patients across Westbrook and the rest of start with a detailed online quiz covering medical history and goals. Dr. Anjmun Sharma personally reviews each intake and connects by secure video, usually inside 48 hours, to decide together whether a compounded GLP-1 is right. When she writes a prescription, the medication is filled by a state-licensed 503(a) pharmacy and mailed to your Westbrook door in temperature-controlled cold-pack packaging. Ongoing follow-ups also happen by video, keeping your plan on track without a single in-person appointment.

Frequently Asked Questions, Westbrook

I am searching for weight loss care near Westbrook. Where are you?

We are based in Costa Mesa, California, where our only physical clinic operates. Patients in Westbrook, Maine connect with us by telehealth instead of visiting. Dr. Anjmun Sharma conducts a video consult to review your goals and confirm whether you qualify for a compounded GLP-1 medication program.

Do I need to be seen in person if I live in Westbrook?

Not at all. The telehealth format covers Westbrook patients from start to finish, so no clinic visit is ever required. You speak with Dr. Sharma by video, and once you are approved, compounded medication ships to Westbrook in cold-pack packaging built to keep it cool and stable.

What are the program costs for Westbrook patients?

The physician review is priced at $119. Compounded semaglutide is available from $166 a month or $499 for the 90-day plan, and tirzepatide from $233 a month. Medication is invoiced separately. Payment options include HSA, FSA, Klarna, and Affirm, and Westbrook patients face no distance surcharge.

What areas of Westbrook do you serve?

We serve patients from across Westbrook by telehealth, including downtown Westbrook and the greater Portland metro area of Cumberland County.

Is my health information private as a Westbrook patient?

Yes. Your intake, video visits, and records are handled under HIPAA safeguards, and medication arrives in discreet packaging. Westbrook patients get the same confidentiality as any telehealth patient.

Westbrook Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Westbrook, Maine by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.